https://www.avient.com/sites/default/files/2022-10/Omnicolor Case Study Plastic Molder.pdf
PLASTIC INJECTION
MOLDER
V A R I O U S M A R K E T S &
A P P L I C A T I O N S
• Ability to use a color concentrate in multiple resins
• Low let down ratio (LDR)
• Color consistency over time
• Offered versatile solution across resins and
in various molding methods
• Provided range of 1-3% LDRs in four
standard colors
• Achieved consistent color in a variety of
products and markets for over 10 years
Omnicolor™ Multipurpose Colorants
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2023-10/Stat-Tech TPE - Conveyor Belt - Case Study Snapshot.pdf
FOOD PROCESSING
BELT MANUFACTURER
C O N V E Y O R B E L T
• Electrical resistivity of E+8 Ω
• FDA and EU 10/2011 food compliant
• Designed to meet ATEX standard
• Light color (white)
• Provided a permanent statically dissipative
solution
• Met stringent compliance requirements
• Reduced manufacturing steps from two-step
process to single-step process
Stat-Tech™ Thermoplastic Elastomer
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2021-01/avient-colorants-sweden-ab-certificate-of-registration.pdf
e-Certificate of registration
Swedish Companies Registration Office
LIMITED COMPANY
D1a- 6064988
Registration number
Date of registration of the company
Document created on
Date of registration of current name
Page
556393-1020
1990-04-10
2020-11-30 14:53
2020-11-30
1 (2)
Registration number: 556393-1020
Business name: Avient Colorants Sweden AB
Address:
Box 9053
200 39 MALMÖ
Registered office: Malmö
Note:
The company is registered as a private limited company.
THE COMPANY WAS FORMED
1990-03-29
SHARE CAPITAL
Share capital...: SEK 3,200,000
Min.............: SEK 3,000,000
Max.............: SEK 12,000,000
Number of shares: 32,000
Min.............: 30,000
Max.............: 120,000
BOARD MEMBER, MANAGING DIRECTOR
660613-3954 Nilsson, Bo Patrik Joakim, Hovslagaregatan 13, 271 57 YSTAD
BOARD MEMBER, CHAIR OF THE BOARD
640503 Merklein, Norbert, Fichtenstrasse 20,
61476 KRONBERG IM TAUNUS, TYSKLAND
BOARD MEMBERS
750618-4089 Norén, Jenny Eva Kristina, Fårabäcksvägen 68, 212 91 MALMÖ
610322 Smeds, Jan-Håkan, Chämiweg 23, NEFTENBACH, TYSKLAND
AUDITORS
556029-6740 Öhrlings PricewaterhouseCoopers AB, Box 4009, 203 11 MALMÖ
Represented by: 710921-4689
PRINCIPALLY RESPONSIBLE AUDITOR
710921-4689 Olsson, Karin Maria, c/o PwC, 405 32 GÖTEBORG
SIGNATORY POWER
e-Certificate of registration
Swedish Companies Registration Office
LIMITED COMPANY
D1a- 6064988
Registration number
Date of registration of the company
Document created on
Date of registration of current name
Page
556393-1020
1990-04-10
2020-11-30 14:53
2020-11-30
2 (2)
The board of directors is entitled to sign.
ARTICLES OF ASSOCIATION
Date of the latest change: 2020-11-02
FINANCIAL YEAR
Registered financial year: 0101 - 1231
Latest annual report submitted covers financial
period 20190101-20191231
DATE OF REGISTRATION OF CURRENT AND PREVIOUS BUSINESS NAMES
2020-11-30 Avient Colorants Sweden AB
2016-01-19 Clariant Plastics & Coatings (Nordic) AB
2000-08-23 Clariant Masterbatches Norden Aktiebolag
1990-05-22 Drycolor Aktiebolag
1990-04-10 Nya Drycolor Aktiebolag
**** The above information is an extract from the Trade and Industry
Register Bolagsverket, the Swedish Companies Registration Office ****
Bolagsverket
851 81 Sundsvall
0771-670 670
bolagsverket@bolagsverket.se
www.bolagsverket.se
2020-11-30T14:53:51+0100
Sweden
Bolagsverket
Bolagsverket intygar äktheten och integriteten för detta dokument
https://www.avient.com/sites/default/files/2024-01/Global Standard Response_Dec 2023.pdf
We thank you for your understanding, and we look forward to serving your needs.
3
Table of contents
A Message from our Global Quality
Manager ...............................................................2
Avient Corporation: Overview ............................4
Avient Policy for Customer Audits ......................5
Management Responsibility ...............................6
Product Liability Insurance .............................6
Ethics - Code of Conduct.................................6
Modern Slavery Statement.............................6
Conflict Mineral Policy....................................6
Technical Data Sheets.....................................6
Safety Data Sheets..........................................6
Regulatory Requests and Certificates
(FDA certificate, Absence declaration,
REACH, SDS) ........................................6
Safety Performance ........................................6
Environmental Performance...........................6
Energy Management ......................................6
Business Continuation Plan.............................6
Preventive - Predictive Maintenance..............6
Financial Report..............................................6
Quality Management..........................................7
3rd Party Certification......................................7
Complaint Handling ........................................7
Continuous Improvement...............................7
Traceability .....................................................7
Record Retention............................................7
IT Security.........................................................8
Firewall .........................................................8
Critical Data ..................................................8
IT Disaster Recovery .....................................8
IT Systems of Use Policy ...............................8
Annex 1 - Special dispositions related to ISO
13485 certification for Mevopur .......................9
Change control .............................................9
Validation .....................................................9
Control of documents and records ...............9
Supplier approval and supplier evaluation ...9
Traceability ...................................................9
Material management ..................................9
Release of finished products.........................9
Control of Non-conforming products,
complaints handling, recall and CAPA..........9
Annex 2 – special dispositions related to ISO
22000 certification............................................10
Change..........................................................10
HACCP ..........................................................10
Control of documents and records ...............10
Material management ..................................10
Supplier approval and supplier evaluation ...10
Traceability ...................................................10
Release of finished products.........................10
Control of Non-conforming products,
complaints handling, recall and CAPA..........10
4
Avient Corporation: Overview
The Avient website is your home base for information about the company:
http://www.avient.com/
To find our facility locations:
http://www.avient.com/contact/global-directory-and-contacts
For more information about our management systems certifications, including ISO, go to:
Avient Governance (corporate policies and the Avient Code of Conduct):
http://www.avient.com/investors/governance
Financial reports:
https://www.avient.com/investors
Avient Sustainability Report:
https://www.avient.com/company/sustainability
http://www.avient.com/
http://www.avient.com/contact/global-directory-and-contacts
http://www.avient.com/investors/governance
https://www.avient.com/investors
https://www.avient.com/company/sustainability
5
Avient Policy for Customer Audits
Avient may permit audits of facilities, subject to:
Advanced notice and an audit agenda provided at least thirty (30) days in
advance or as agreed by the Avient location to be audited for a routine audit
https://www.avient.com/company/policies-and-governance/it-systems-use-policy
9
10
Annex 1 - ISO 13485 certification for Mevopur manufacturing sites North America
& EMEA.
Validation
Avient Colorants Sweden AB and Avient Colorants
Lewiston, ME follow the Global Harmonization Task
Force guideline GHTF/SG3/N99-10 to define the
procedure for process validation.
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520Jefferies%2520Conf%2520w%2520Non%2520GAAP%252008%252012%25202014.pdf
You are
advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and
Exchange Commission.
PolyOne Corporation Page 3
PolyOne Commodity to Specialty
Transformation
• Volume driven,
commodity
producer
• Heavily tied to
cyclical end
markets
• Performance largely
dependent on non-
controlling joint
ventures
2000-2005 2006 - 2009 2010 – 2014 2015 and
beyond
• Steve Newlin
appointed,
Chairman,
President and CEO
• New leadership
team appointed
• Implementation of
four pillar strategy
• Focus on value
based selling,
investment in
commercial
resources and
innovation to drive
transformation
• 19 consecutive
quarters of double-
digit adjusted EPS
growth
• Shift to faster
growing, high
margin, less cyclical
end markets
• Key acquisitions
propel current and
future growth, as
well as margin
expansion
• Established
aggressive 2015
targets
• Continue specialty
transformation
• Goal of $2.50
Adjusted EPS by
2015, nearly double
2013 EPS
• Drive double digit
operating income
and adjusted EPS
growth
PolyOne Corporation Page 4
Building &
Construction
13%
Industrial
12%
18%
Wire & Cable
9%
Packaging
16%
10%
HealthCare
11% Appliance
Electronics &
Electrical
5%
2013 Revenues: $3.8 Billion
End Markets
2013 Revenues: $3.8 Billion
PolyOne
At A Glance
United
States
67%
Europe
14%
Canada
7% Asia
Latin
America
Specialty
54%
PP&S
18%
Distribution
28%
$13
$31
$46 $46
$92 $96
$122
$195
$0
$50
$100
$150
$200
2006 2007 2008 2009 2010 2011 2012 2013
Specialty Operating Income
PolyOne Corporation Page 5
Old
PolyOne Transformation
*Operating Income excludes corporate charges and special items
2%
34% 43%
62%
66%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2013 2014 YTD 2015
%
o
f O
pe
ra
tin
g
In
co
m
e*
JV's Performance Products & Solutions Distribution Specialty
65-75%
Specialty OI $5M $46M $87M $195M $129M Target
Mix Shift Highlights Specialty Transformation
2015
Target
PolyOne Corporation Page 6
Confirmation of Our Strategy
The World’s Premier Provider of Specialized
Polymer Materials, Services and Solutions
Specialization Globalization
Operational
Excellence
Commercial
Excellence
PolyOne Corporation Page 7
-150%
-50%
50%
150%
250%
350%
450%
550%
POL S&P 500
Strategy and Execution Drive Results
$0.12
$0.27
$0.21
$0.13
$0.68
$0.82
$1.00
$1.31
'06 '07 '08 '09 '10 '11 '12 '13
‘06-‘13 EPS CAGR = 41%
EPS Share Price vs.
S&P 500
All time high of
$43.34
July 1st, 2014
PolyOne Corporation Page 8
2006 2014 YTD 2015
“Where we were” “Where we are” Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 15.2% 12 – 16%
Global Specialty Engineered
Materials 1.1% 11.8% 12 – 16%
Designed Structures & Solutions -- 7.1% 8 – 10%
Performance Products &
Solutions 5.5% 8.0% 9 – 12%
Distribution 2.6% 6.0% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 66% 65 – 75%
3) ROIC* 5.0% 9.9% 15%
4) Adjusted EPS Growth N/A 40% Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
(Est. in 2012)
PolyOne Corporation Page 9
Bridge to $2.50 Adjusted EPS by 2015
2015 EPS: $2.50
2013 EPS: $1.31
Continued Gross Margin
Expansion
Mergers & Acquisitions
Spartech Accretion
Incremental Share Buybacks
Ongoing LSS Programs
(50-100 bps/yr)
Accelerated Innovation
& Mix Improvement Several Levers to
Drive Growth
Mid Single Digit Revenue CAGR
PolyOne Corporation Page 10
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$53
2006 2013
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index
Progression*
14.3%
30.7%
2006 2013
Specialty Platform
Gross Margin %
19.5%
43.0%
2006 2013
Specialty Vitality Index Target ≥ 35%
PolyOne Corporation Page 11
Prototype Frame
Opportunity
Scale-up &
Test Market
Build
Business Case
Commercial
Launch
Phase
1
Phase
2
Phase
3
Phase
4
Phase
5
4
11
5
10
6
9
3 4 2
15
9
1
10
4
Breakthrough
Platform
Derivative
A Rich Pipeline of Opportunity*
Number of Projects 25 14 19 17 18 93
Addressable Market
($ millions) TBD TBD $800 $450 $450 $1,700
*Pipeline as of May 29, 2014 as presented during our Innovation Day
PolyOne Corporation Page 12
Healthcare
Consumer
Packaging and Additive Technology
Transportation
Unique and Innovative Solutions
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG
PolyOne Corporation Page 13
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 14
60%
100%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2014
Pension Funding**
As of June 30, 2014
Debt Maturities & Pension Funding – 6/30/14
Net Debt / EBITDA* = 1.8x
$48
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of June 30, 2014
($ millions)
Coupon Rates: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 6/30/2014
PolyOne Corporation Page 15
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
$0.16
$0.20
$0.24
$0.32
$0.10
$0.20
$0.30
$0.40
2011 2012 2013 2014
Annual Dividend
Expanding our sales, marketing,
and technical capabilities
Targets that expand our:
• Specialty offerings
• End market presence
• Geographic footprint
• Operating Margin
Synergy opportunities
Adjacent material solutions
Repurchased 1.8 million shares in
Q2 2014
Repurchased 8.2 million
shares since early 2013
11.8 million shares are
available for
repurchase under the
current authorization
Organic
Growth
Acquisitions
Share
Repurchases
Dividends
Investing in operational and
LSS initiatives (including
synergy capture)
Manufacturing alignment
PolyOne Corporation Page 16
PolyOne Core Values
Innovation
Collaboration
Excellence
PolyOne Corporation Page 17
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520BOAML%2520Basic%2520Materials%2520Conference%2520w%2520non-GAAP%252012%252011%25202014.pdf
You are
advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and
Exchange Commission.
PolyOne Corporation Page 4
PolyOne Commodity to Specialty
Transformation
• Volume driven,
commodity
producer
• Heavily tied to
cyclical end
markets
• Performance largely
dependent on non-
controlling joint
ventures
2000-2005 2006 - 2009 2010 – 2014 2015 and
beyond
• Steve Newlin
appointed,
Chairman,
President and CEO
• New leadership
team appointed
• Implementation of
four pillar strategy
• Focus on value
based selling,
investment in
commercial
resources and
innovation to drive
transformation
• 20 consecutive
quarters of double-
digit adjusted EPS
growth
• Shift to faster
growing, high
margin, less cyclical
end markets
• Key acquisitions
propel current and
future growth, as
well as margin
expansion
• Established
aggressive 2015
targets
• Continue specialty
transformation
• Goal of $2.50
adjusted EPS by
2015, three times
the EPS generated
in 2011 of $0.82
• Drive double digit
operating income
and adjusted EPS
growth
PolyOne Corporation Page 5
Building &
Construction
13%
Industrial
12%
Transportation
18%
Wire & Cable
9%
Packaging
16%
Consumer
10%
HealthCare
11% Appliance
Electronics &
Electrical
5%
2013 Revenues: $3.8 Billion
End Markets
2013 Revenues: $3.8 Billion
PolyOne
At A Glance
United
States
67%
Europe
14%
Canada
7% Asia
Latin
America
Specialty
54%
PP&S
18%
Distribution
28%
$13
$31
$46 $46
$92 $96
$122
$195
$0
$50
$100
$150
$200
2006 2007 2008 2009 2010 2011 2012 2013
Specialty Operating Income
PolyOne Corporation Page 6
Old
PolyOne
*Operating Income excludes corporate charges and special items
2%
34% 43%
62%
65%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2013 2014 YTD 2015
%
o
f O
pe
ra
tin
g
In
co
m
e*
JV's Performance Products & Solutions Distribution Specialty
65-75%
Specialty OI $5M $46M $87M $195M $191M Target
Mix Shift Highlights Specialty Transformation
Transformation 2015
Target
PolyOne Corporation Page 7
Confirmation of Our Strategy
The World’s Premier Provider of Specialized
Polymer Materials, Services and Solutions
Specialization Globalization
Operational
Excellence
Commercial
Excellence
PolyOne Corporation Page 8
Strategy and Execution Drive Results
$0.12
$0.27
$0.21
$0.13
$0.68
$0.82
$1.00
$1.31
'06 '07 '08 '09 '10 '11 '12 '13
‘06-‘13 EPS CAGR = 41%
EPS Share Price vs.
S&P 500
-150%
-50%
50%
150%
250%
350%
450%
550%
POL S&P 500
All time high of
$43.34
July 1st, 2014
PolyOne Corporation Page 9
2006 2014 YTD 2015
“Where we were” “Where we are” Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 14.9% 12 – 16%
Global Specialty Engineered
Materials 1.1% 12.1% 12 – 16%
Designed Structures & Solutions -- 7.6% 8 – 10%
Performance Products &
Solutions 5.5% 8.1% 9 – 12%
Distribution 2.6% 6.2% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 65% 65 – 75%
3) ROIC* 5.0% 10.6% 15%
4) Adjusted EPS Growth N/A 37% Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
PolyOne Corporation Page 10
32% Adjusted EPS CAGR from 2011
2015 EPS: $2.50
2011 EPS: $0.82
Continued Gross Margin
Expansion
Mergers & Acquisitions
Spartech Accretion
Incremental Share Buybacks
Ongoing LSS Programs
(50-100 bps/yr)
Accelerated Innovation
& Mix Improvement Several Levers to
Drive Growth
Mid Single Digit Revenue Growth
PolyOne Corporation Page 11
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$53
2006 2013
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14%
31%
2006 2013
Specialty Platform
Gross Margin %
20%
43%
2006 2013
Specialty Vitality Index Target ≥ 35%
Vitality Products
+ 700 to 1000 bps
PolyOne Corporation Page 12
Prototype Frame
Opportunity
Scale-up &
Test Market
Build
Business Case
Commercial
Launch
Phase
1
Phase
2
Phase
3
Phase
4
Phase
5
4
11
5
10
6
9
3 4 2
15
9
1
10
4
Breakthrough
Platform
Derivative
A Rich Pipeline of Opportunity
Number of Projects 25 14 19 17 18 93
Addressable Market
($ millions) TBD TBD $800 $450 $450 $1,700
PolyOne Corporation Page 13
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 14
60%
100%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2014
Pension Funding**
As of September 30, 2014
Debt Maturities & Pension Funding – 9/30/14
Net Debt / EBITDA* = 1.7x
$48
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of September 30, 2014
($ millions)
Coupon Rates: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 9/30/2014
PolyOne Corporation Page 15
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
Expanding our sales, marketing,
and technical capabilities
Targets that expand our:
• Specialty offerings
• End market presence
• Geographic footprint
• Operating Margin
Synergy opportunities
Adjacent material solutions
Repurchased 1.5 million shares in
Q3 2014
Repurchased 9.7 million
shares since early 2013
10.3 million shares are
available for
repurchase under the
current authorization
Organic
Growth
Acquisitions
Share
Repurchases
Dividends
Investing in operational and
LSS initiatives (including
synergy capture)
Manufacturing alignment
$0.16
$0.20 $0.24
$0.32
$0.40
$0.10
$0.20
$0.30
$0.40
$0.50
2011 2012 2013 2014 2015
Annual Dividend
PolyOne Corporation Page 16
PolyOne Core Values
Innovation
Collaboration
Excellence
PolyOne Corporation Page 17
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2020-10/investing-in-avient.pdf
You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.
WHY AVIENT WINS
7
Deep Customer Relationships
& Application Know-How
Superior Design Capabilities
& Advanced Analytics
Global Footprint Strategically
Aligned to Serve Customers
We iterate fast and often.
37 24
10
36
• U.S. and Canada
• Latin America
• Europe, Middle East & Africa
• Asia
We produce locally, serve globally.
These investments also
consider our global footprint, and we are positioned very well and
strategically from a regional perspective.
9
Growth Drivers
2020E
Revenue
Long-Term
Growth Rate
Sustainable Solutions $ 550 8–12%
Healthcare 520 8–10%
Composites / 5G 200 10%
Growth in Emerging Regions 650 5%
Other (GDP growth) 1,730 2–3%
Pro Forma Avient $ 3,650 6.5%
(1) Avient Sustainable Solutions definitions aligned with FTC 2012 Guide for the Use of Environmental Marketing Claims (“Green Guides”)
(2) 2020 is estimated and Pro forma to include full year of the Clariant Masterbatch business
SUSTAINABLE SOLUTIONS
Avient has a highly technical and broad portfolio of material solutions
that help our customers—and our planet—be more sustainable.
https://www.avient.com/sites/default/files/2020-09/versaflex-pf-technical-bulletin-sept-2020-es-la.pdf
VERSAFLEX™ PF
Capa de adherencia Versaflex™ PF para
películas de protección de superficies
BOLETÍN TÉCNICO
Propiedades Versaflex PF
MD6727
Versaflex PF
MD6741
Versaflex PF
MD6649
Versaflex PF
9512
Versaflex PF
MD6666
Versaflex PF
MD6748
Versaflex PF
MD6700
Características Baja adherencia
Baja adherencia; se utiliza
para ajustar el revestimiento
con MD6700
Baja-media adherencia Oferta de valor
Adherencia media
Bajo contenido
de gel/residuos
Construcción de baja
adherencia Alta adherencia
Resistencia al
desprendimiento Baja Baja-media Media Media-Alta Media-Alta Alta Alta
Aplicaciones Películas ópticas Electrodomésticos Plásticos Construcción / Metales
sin recubrimiento Metales acabados Acero/Metales pintados Metales sin recubrimiento
MFR a 190 °C/2,16 kg -- 4,5 17 5,4 21 4,8 6,5
MFRa@ 230 °C/2,16 kg 10 20 -- -- -- -- --
Gravedad específica, g/cc 0,92 0,91 0,92 0,92 0,94 0,94 0,94
Dureza, Límite A 50 49 37 38 37 31 30
G' a 23 °C, Pa 28,0 x 105 10,4 x 106 8,3 x 105 -- 9,9 x 105 11,8 x 105 10,0 x 105
Tg DMA, °C -29 -30 -9 10 11 15 21
Película LDPE/Versaflex PF1 Desprendimiento de 180°, N/25 mm
Acero inoxidable
después de 20 minutos
a 25 °C 0,5 2,2 3,2 6,1 6,7 8,5 8,6
después de 7 días
a 25 °C 0,6 2,7 4,3 5,5 8,2 8,3 10,3
PMMA2
después de 20 minutos
a 25 °C 1,1 1,7 3,8 4,9 6,9 8,3 8,8
después de 20 minutos
a 75 °C 2,8 4,1 5,1 6,9 9,0 10,7 11,8
después de 7 días
a 75 °C 4,0 4,4 5,9 9,8 8,4 9,8 10,3
Policarbonato3
después de 20 minutos
a 25 °C 1,4 2,2 3,8 6,8 6,3 8,4 7,0
después de 20 minutos
a 75 °C 3,4 4,8 6,7 8,8 8,8 10,0 11,8
después de 7 días
a 75 °C 4,6 6,5 7,5 10,6 11,6 10,6 13,8
1 Grosor de la película: LDPE de 51 micras/Versaflex PF de 25 micras.
2 Arkema Plexiglas™ V052-100 (Plexiglas es una marca comercial de Arkema France Corp).
3 Sabic Lexan™ L52-111 (Lexan es una marca comercial de Sabic Innovative Plastics).
Electrodomésticos.
• Construcción y materiales de construcción.
• Mobiliario y gabinetes.
• Automoción y otros medios de transporte.
100/0 90/10 80/20 70/30 60/40 40/60 30/70 20/80 10/90 0/100
0,9
1,1
2,0
2,4
2,8
3,7
3,8
4,9
0
1
2
3
4
6
7
8
6,5
1,6
MD6727
MD6748
MD6700
MD6666
9512
MD6649
MD6741
0
2
4
6
8
10
12
% de MD6741/MD6700
El grado de adherencia puede personalizarse para superficies de sustrato.
https://www.avient.com/sites/default/files/2024-06/Infant Care Product Bulletin_Selector Guide.pdf
GLS™ TPE
INFANT CARE SOLUTIONS
REGULATORY COMPLIANT
MATERIALS FOR YOUR
BABY CARE PRODUCTS
GRADE PRODUCT HARDNESS REGULATORY COMPLIANCE* – FDA, EU, GB
CL2242
Pacifiers
Teething
43
Shore A FDA 177.1210 — —
Versaflex™
CL2250
Pacifiers
Teething
50
Shore A FDA 177.1210 — —
Versaflex™
FFC 2882-87
87
Shore A FDA 177.2600 EU 10/2011 GB 9685-2008
FFC 2882-50
50
Shore A FDA 177.2600 EU 10/2011 —
G2701C
66
Shore A FDA 177.2600 — —
Dynaflex™
G6770
69
Shore A FDA 177.2600 EU 10/2011 GB 9685-2008
Dynaflex™
G2780C
84
Shore A FDA 177.2600 — —
Dynaflex™
G7600 series
30A-80 Shore
A FDA 177.1210 — —
Dynalloy™
GP 7810 & 7820
Bathtubs
Bibs
Placemats
30A-70 Shore
A General FDA — —
We believe that the smallest consumers deserve the very best.
https://www.avient.com/investor-center/news/polyone-announces-full-year-and-fourth-quarter-2018-results
Adjusted EPS increased 10% to $2.43, representing the 9th consecutive year of adjusted EPS growth
Adjusted earnings per share in 2018 increased 10% to
You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the